anti-p62 / SQSTM1 (C-terminus) guinea pig polyclonal, serum

Autophagy assay cell type - CaCo-2

Experiment
Autophagy assay cell type - CaCo-2
Product
anti-p62 / SQSTM1 (C-terminus) guinea pig polyclonal, serum from Progen
Manufacturer
Progen

Protocol tips

Protocol tips
- For IHC, use promary Ab dilution at 1:600 and for Western Blot use between 1:1,000 – 1:3,000

Publication protocol

Cellular localization of autophagy biomarkers and NFE2L2

Subcellular localization of SQSTM1, NFE2L2 and LC3B was determined by immunostaining and visualization by fluorescently labeled secondary antibodies. Immunostaining was imaged by an Axiovert200 microscope equipped with a 63×1.2W objective and the confocal module LSM510 META (Carl Zeiss). Images were processed using the LSM software (Carl Zeiss) and mounted using Canvas 11 (ACD Systems). Images are representative of more than 200 randomly selected cells in each condition and of two or more independent experiments. Cytoplasmic structures enriched for LC3 were quantified by using the histogram function in the LSM software. All images were taken with the same settings. Pixels positive for LC3B with an intensity of more than 100 RLU were counted and divided by the number of cells in the image (more than 100 cells per condition).

Autophagy determined by flow cytometry

Autophagic structures were determined using the CytoID autophagy detection kit following the suppliers’ instructions (Enzo Life Sciences). Briefly, the cells were detached by trypsination and stained in a solution with Cyto-ID Detection Reagent covered from light for 30 min at room temperature with gentle rotation, and the fluorescent intensity per cell was determined using a flow cytometer.

Immunoblotting

Cells, transfected or non-transfected, untreated or treated with DHA and/or 100 nM BafA1, were harvested by trypsinization or scraped in ice cold PBS. Cells were lysed in either a buffer containing 1% NP40, 0.25% Triton-X100, 50 mM Tris–HCl (pH 8.0), 150 mM NaCl, 1 mM EDTA pH 8, Complete® protease inhibitor (PI, Roche), and phosphatase inhibitor cocktail I and III (Sigma-Aldrich), or an urea buffer containing 8 M Urea, 0.5% (v/v) Triton X-100, 100 mM DTT, PI, and phosphatase inhibitor cocktail I and III. Total protein concentration in the lysates was determined by Bio-Rad protein assay (Bio-Rad). Bound antibodies were imaged by near infrared fluorescence using appropriate fluorescent dye labeled secondary antibodies and an Odyssey NIR scanner (Li-Cor Biosciences). Images were processed using the Li-Cor Odyssey software and mounted using the Canvas 11 software (ACD Systems).

Full paper   Login or join for free to view the full paper.

Reviews

anti-p62 / SQSTM1 (C-terminus) guinea pig polyclonal, serum from Progen has not yet been reviewed for this experiment

We'd love it if you would be the first to write a review!

Discussion

Start your discussion

Share your thoughts or question with experts in your field

Start a discussion

Papers

Check out relevant papers found by Labettor's AI that are relevant for performing Autophagy assay cell type - CaCo-2 using anti-p62 / SQSTM1 (C-terminus) guinea pig polyclonal, serum from Progen.

Paper title
DHA-induced stress response in human colon cancer cells - Focus on oxidative stress and autophagy.
Full paper
Login or join for free to view the full paper.

Manufacturer protocol

Download the product protocol from Progen for anti-p62 / SQSTM1 (C-terminus) guinea pig polyclonal, serum below.

We haven't found the manufacturer protocol for this product yet.

Videos

Check out videos that might be relevant for performing Autophagy assay cell type - CaCo-2 using anti-p62 / SQSTM1 (C-terminus) guinea pig polyclonal, serum from Progen. Please note that these videos are representative and steps or experiment specific processes must be kept in mind to expect desired results.

We haven't found any additional videos for this experiment / product combination yet.

Outsource your experiment

Fill out your contact details and receive price quotes in your Inbox

  Outsource experiment
Become shareholder Discussions About us Contact Privacy Terms